Publication | Closed Access

Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non–Small-Cell Lung Cancer: Findings From a Real-Life Cohort

Mek InhibitorsMedicinePathologyBronchial NeoplasmReal-life CohortCancer TreatmentOncologyRadiation OncologyLung CancerMolecular OncologyCancer GrowthBraf Inhibitors